I'm LongbridgeAI, I can summarize articles.D.A. Davidson analyst Chris Dankert maintains a Hold rating on Emerson (EMR), raising the price target to $155 and lifting long-term forecasts. The neutral stance reflects balanced risk-reward, citing strong secular growth in power generation and LNG, offset by valuation caution due to execution risks and geopolitical headwinds. BMO Capital also issued a Hold rating with a $175 target on August 6.
D.A. Davidson analyst Chris Dankert has maintained their neutral stance on EMR stock, giving a Hold rating on August 6.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Chris Dankert has given his Hold rating due to a combination of factors related to valuation and growth balance. He acknowledges Emerson’s strong positioning in secular themes such as growing power generation needs, LNG expansion, and near- or reshoring trends, and he modestly lifts long‑term earnings forecasts while raising the price target to $155, implying limited upside from current levels.
At the same time, his valuation work applies a multiple slightly below the company’s recent five‑year average, reflecting caution around execution risks, including potential project delays and geopolitical headwinds that have already modestly weighed on sales. While he sees the company on track to meet its medium‑term earnings targets and supported by cash for bolt‑on acquisitions, he views the risk‑reward profile as balanced rather than compelling, leading him to maintain a neutral, or Hold, stance on the shares.
In another report released on August 6, BMO Capital also assigned a Hold rating to the stock with a $175.00 price target.